Norman W. Baylor

927 total citations
16 papers, 525 citations indexed

About

Norman W. Baylor is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, Norman W. Baylor has authored 16 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Health and 5 papers in Epidemiology. Recurrent topics in Norman W. Baylor's work include Vaccine Coverage and Hesitancy (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Influenza Virus Research Studies (5 papers). Norman W. Baylor is often cited by papers focused on Vaccine Coverage and Hesitancy (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Influenza Virus Research Studies (5 papers). Norman W. Baylor collaborates with scholars based in United States, United Kingdom and Netherlands. Norman W. Baylor's co-authors include William Egan, Paul G. Richman, R R Wagner, F W Ruscetti, Tao Fu, Yonghong Yan, Florence Houn, Yàn Li, Robert R. Wagner and Zhiping Ye and has published in prestigious journals such as PEDIATRICS, Journal of Virology and Journal of Bacteriology.

In The Last Decade

Norman W. Baylor

16 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Norman W. Baylor United States	8	179	173	145	119	58	16	525
Carine Rouanet France	14	231 1.3×	336 1.9×	141 1.0×	317 2.7×	142 2.4×	20	847
Jeong-Joong Yoon United States	16	180 1.0×	434 2.5×	84 0.6×	455 3.8×	35 0.6×	22	912
Dorothy Xing United Kingdom	20	192 1.1×	440 2.5×	85 0.6×	168 1.4×	19 0.3×	55	950
Joerg Doellinger Germany	15	329 1.8×	170 1.0×	33 0.2×	152 1.3×	42 0.7×	38	792
Shisong Fang China	14	229 1.3×	244 1.4×	103 0.7×	352 3.0×	28 0.5×	65	866
Freda E.‐C. Jen Australia	17	388 2.2×	252 1.5×	78 0.5×	120 1.0×	46 0.8×	47	912
Portia M. Gillespie United States	18	276 1.5×	195 1.1×	99 0.7×	191 1.6×	52 0.9×	20	945
Shujun Chai China	11	143 0.8×	77 0.4×	45 0.3×	86 0.7×	12 0.2×	29	427
Xiaoli Xu China	14	521 2.9×	197 1.1×	85 0.6×	374 3.1×	118 2.0×	38	888
Georges H. Werner France	14	311 1.7×	161 0.9×	155 1.1×	91 0.8×	18 0.3×	47	736

Countries citing papers authored by Norman W. Baylor

Since Specialization

Citations

This map shows the geographic impact of Norman W. Baylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman W. Baylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman W. Baylor more than expected).

Fields of papers citing papers by Norman W. Baylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman W. Baylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman W. Baylor. The network helps show where Norman W. Baylor may publish in the future.

Co-authorship network of co-authors of Norman W. Baylor

This figure shows the co-authorship network connecting the top 25 collaborators of Norman W. Baylor. A scholar is included among the top collaborators of Norman W. Baylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman W. Baylor. Norman W. Baylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Gasperini, Gianmarco, Norman W. Baylor, Steve Black, et al.. (2025). Vaccinology in the artificial intelligence era. Science Translational Medicine. 17(794). eadu3791–eadu3791. 1 indexed citations

Moore, Penny L., T. Leighton, Julie Ostrowsky, et al.. (2023). A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy. Vaccine. 41(13). 2101–2112. 18 indexed citations

Giersing, Birgitte, Richard Isbrucker, David C. Kaslow, et al.. (2023). Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries. The Lancet Global Health. 11(11). e1819–e1826. 11 indexed citations

Ballou, W. Ripley, Norman W. Baylor, Victor J. Dzau, et al.. (2022). The Influenza Imperative: An Urgent Need to Leverage Lessons from COVID-19 to Prepare for a Global Response to Seasonal and Pandemic Influenza. NAM Perspectives. 9. 2 indexed citations

Baylor, Norman W. & Jesse L. Goodman. (2022). Vaccine Preparedness for the Next Influenza Pandemic: A Regulatory Perspective. Vaccines. 10(12). 2136–2136. 4 indexed citations

Baylor, Norman W.. (2021). The Regulatory Evaluation of Vaccines for Human Use. Methods in molecular biology. 2412. 483–501. 1 indexed citations

Baylor, Norman W.. (2021). Human Challenge Studies for Vaccine Development. Current topics in microbiology and immunology. 445. 33–40. 1 indexed citations

Baylor, Norman W.. (2017). Role of the national regulatory authority for vaccines. International Journal of Health Governance. 22(3). 128–137. 2 indexed citations

Baylor, Norman W., et al.. (2011). Food and Drug Administration Regulation and Evaluation of Vaccines. PEDIATRICS. 127(Supplement_1). S23–S30. 34 indexed citations

10.

Baylor, Norman W. & Florence Houn. (2009). Considerations for Licensure of Influenza Vaccines with Pandemic and Prepandemic Indications. Current topics in microbiology and immunology. 333. 453–470. 10 indexed citations

11.

Baylor, Norman W., William Egan, & Paul G. Richman. (2002). Aluminum salts in vaccines—US perspective. Vaccine. 20. S18–S23. 276 indexed citations

12.

Baylor, Norman W., Tao Fu, Yonghong Yan, & F W Ruscetti. (1992). Inhibition of Human T Cell Leukemia Virus by the Plant Flavonoid Baicalin (7-Glucuronic Acid, 5,6-Dihydroxyflavone). The Journal of Infectious Diseases. 165(3). 433–437. 52 indexed citations

13.

Baylor, Norman W., et al.. (1989). Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. Journal of Virology. 63(9). 3586–3594. 93 indexed citations

14.

Baylor, Norman W., Yàn Li, Zhiping Ye, & Robert R. Wagner. (1988). Transient expression and sequence of the matrix (M1) gene of wsn influenza a virus in a vaccinia vector. Virology. 163(2). 618–621. 14 indexed citations

15.

Baylor, Norman W., et al.. (1983). Molecular characterization of ilvC specialized transducing phages of Escherichia coli K-12. Molecular and General Genetics MGG. 191(3). 347–352. 4 indexed citations

16.

Williams, Arthur L., Norman W. Baylor, & Mark Ensor. (1981). Evidence for the Site of Lambda Insertion in the ilv Gene Cluster of Escherichia coli K-12. Journal of Bacteriology. 147(2). 691–693. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact